Cardiovascular risk in women with metabolic dysfunction-associated steatotic liver disease across the menopausal transition

European Journal of Preventive Cardiology 2026

View at publisher
Authors: You-Jung Choi, Sungho Bea, Sung won Chung, Ho-Tack Seo, Tae‐Min Rhee, Chan Soon Park, Heesun Lee, Kyung-Do Han, Yong Jin Kim, Hyung Kwan Kim, Jun‐Bean Park
DOI: 10.1093/eurjpc/zwag254
Cited by: 1
References: 47

Abstract

AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) poses a substantial global health burden, yet the cardiovascular impact across menopausal status remains unclear. Thus, this study aimed to assess the association between MASLD and cardiovascular risk in premenopausal and postmenopausal women. METHODS AND RESULTS: We conducted a nationwide population-based cohort study using the Korean National Health Insurance Service database. Women aged 40 years or older were categorized by the fatty liver index as having no MASLD (

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
European Journal of Preventive Cardiology
Publisher
Oxford University Press (OUP)
Publication date
2 May 2026
Language
EN